Daily Financial Update
Market Pulse: U.S. stocks are wobbling after a mixed bag of earnings surprises and cautious guidance, leaving traders on edge heading into today’s open.
Key Movers: Planet Labs beat estimates and raised guidance yet slid, Lupin snagged FDA approval for modafinil tablets, and cybersecurity names like Zscaler topped results but still retreated.
Macro & Politics: A scorching jobs report sent rate-hike odds back up, reigniting hawkish Fed chatter and squeezing risk assets under the weight of policy uncertainty.
What’s Next: Watch for the Fed minutes and upcoming CPI release—they’ll set the next big tilt in market sentiment.
📈 Breaking Financial News
Stock Market Today, Sept. 4: Planet Labs Dips 1% Despite Earnings Beat, Full-Year Guidance Raise
Planet Labs PBC (NYSE:PL), a daily satellite imagery and geospatial analytics provider, closed at $18.11, down 1.28%. Shares slipped after mixed premarket analyst updates, following Thursday's earnings beat and guidance raise. Trading volume reached 30.8M sha…
Lupin Receives U.S. FDA Approval for Modafinil Tablets, USP
MUMBAI, India and NAPLES, Fla., Sept. 4, 2026 /PRNewswire/ — Global pharmaceutical leader Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Dru…
Zscaler Falls 4% as FY2027 Growth Guidance Overshadows Earnings Beat; CrowdStrike Slips, Palo Alto Holds Steady
Zscaler posted a clean earnings beat and still sent the whole cybersecurity sector into retreat, raising an uncomfortable question about whether even the str…
Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money
Both Intuitive Surgical and Stryker just posted their fifth straight earnings beat, and Wall Street is cheering for both. But a structural difference buried…
Avis Budget Group Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Avis Budget Group, Inc. – CAR
NEW ORLEANS, Sept. 4, 2026 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 29, 2026 to file lead plaintiff applications in a securities class action lawsuit against Avis Budget Group, Inc. …
AI Agents
Elon just created a device he believes will be “the biggest product ever.” He thinks it could 70x investors' money. And he's about to make a major announcement… By the end of this month. Maybe even tomorrow on X.
🔍 Market Analysis & Insights
How the hunger for a new weight loss drug is feeding an industry of fakes
Counterfeit versions of a drug which is still in clinical trials are flooding the black market.
Crypto Traders Are Pairing Meme Coins With Stocks on Robinhood—and It's Working (Sort Of)
A meme coin called BONER cornered half of Hims & Hers Health's tokenized shares on Robinhood's new blockchain. It started a new trend that's spreading fast.
Crypto Biz: AI took a back seat when Bitcoin started climbing
Corporate crypto bets are getting bigger as rising markets reward direct exposure, putting balance-sheet strategies and institutional adoption back in focus.
McDonald's Stock Hits 52-Week Low Near $257 as U.S. Traffic Slows and Investors Await Chicago Strategy Day
McDonald's shares have reached a one-year low as U.S. customer visits decline, despite strong earnings. The company aims to address these challenges with new leadership and strategic initiatives.
GameStop Shares Steady Ahead Of Sept. 8 Earnings As Investors Brace For A Potential 9% Stock Swing Today
GameStop's upcoming earnings report and potential eBay acquisition are pivotal, with investors eyeing strategic shifts amid declining retail sales and growing investment gains.
Oil Skimming
The Oil “Red Zone” Is Coming. It Could Wipe You Out. The International Energy Agency is warning of a coming “red zone” in the oil markets, and it could be brutal for the U.S. economy. But if you see it coming, you could “skim” off big bucks. Get the Facts
💰 Investment Opportunities
MIMRYLO Approval Triggered $275M Payments for Protagonist (PTGX). Are Royalties the Better Commercial Model?
U.S. Food and Drug Administration approval of MIMRYLO, or rusfertide, for erythrocytosis in adults with polycythemia vera triggered $275 million in payments…
Quanex Building Products Q3 Earnings Call Highlights
Quanex Building Products (NYSE:NX) reported third-quarter fiscal 2026 sales of $501.8 million, up 1.3% from $495.3 million a year earlier, as higher pricing…
Bitcoin Slides as Blowout Jobs Report Revives Fed Hike Odds
The Dow dropped 226 points and Bitcoin erased some of its gains after August payrolls tripled estimates, pushing September rate-hike odds to 58%.
Wall Street just poured nearly $900 million into Bitcoin and Ethereum ETFs
Bitcoin funds recorded their third-biggest inflow day of 2026, while Ether products reversed the prior session's outflow. The post Wall Street just poured nearly $900 million into Bitcoin and Ethereum ETFs appeared first on CryptoSlate.
Nvidia bags Hugging Face, AI models play leapfrog and CrowdStrike doubles down on AI
Perhaps it’s no surprise that Nvidia ended up embracing open artificial intelligence model archive Hugging Face this week following more than a week of rumors. Even at almost $13 billion, it may end up being a steal — especially for a company that had $24 bil…
When the market was closed, this was happening
Headlines: When the market was closed, this was happening The trade that happened while the market was closed The Monday surprise no one saw coming Why a quiet Friday afternoon was anything but The weekend result that started on Friday On a quiet Friday afternoon, a trader saw a small, overlooked
Market Commentary
Everyone’s sleeping on the counterfeit-pill epidemic bubbling under the weight-loss drug craze (“How the hunger for a new weight loss drug is feeding an industry of fakes,” BBC News). Regulators scrambling over fake therapeutics could choke real supply chains—don’t be surprised if pharma tickers jump at any crackdown rumors.
Here’s a thesis you haven’t heard: the Fed’s revived hawk stance after the blowout jobs data (Decrypt) will pinch not just equities but also crypto—”Bitcoin Slides as Blowout Jobs Report Revives Fed Hike Odds.” When Zscaler (24/7 Wall St.) can beat on earnings and still slip 4%, you know risk assets aren’t getting a free ride.
Your move: rotate into high-conviction generics plays like Lupin ahead of further FDA nods, and hedge your portfolio against renewed Fed tightening. Get positioned now—waiting until everyone else wakes up will cost you.